ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Connecticut » Psychiatry

Top Psychiatry Prescribers in Connecticut

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
BASSAM AWWA MD

Psychiatry

8,011

$1.13M

434
101 are 65+

18%
patients receiving schedule two controlled substances

Avg: 2%

10%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 24%

$141
Average prescription price

Avg: $130

MARK WAYNIK MD

Psychiatry

7,247

$1.08M

465
231 are 65+

6%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 24%

$149
Average prescription price

Avg: $130

IRENE ABRAMOVICH M.D.

Psychiatry

6,840

$1.43M

166
12 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 24%

$209
Average prescription price

Avg: $130

TADEUSZ RACHWAL MD

Psychiatry

6,208

$798K

235
18 are 65+

5%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$129
Average prescription price

Avg: $130

WILLIAM ECKERD M.D.

Psychiatry

5,600

$745K

280
73 are 65+

8%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

11%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 24%

$133
Average prescription price

Avg: $130

KINSON LEE MD

Psychiatry

5,536

$764K

212
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$138
Average prescription price

Avg: $130

MARK MITTAUER MD

Psychiatry

5,470

$768K

262
52 are 65+

8%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$140
Average prescription price

Avg: $130

J P AUGUSTINE NOONAN MD

Psychiatry

5,349

$674K

340
141 are 65+

9%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 24%

$126
Average prescription price

Avg: $130

JAYAPRAKASH SHETTY MD

Psychiatry

5,124

$515K

306
53 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

12%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 24%

$101
Average prescription price

Avg: $130

KARL LIEBMANN MD

Psychiatry

5,011

$605K

232
32 are 65+

6%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 24%

$121
Average prescription price

Avg: $130

ROBERT WHITE MD

Psychiatry

4,877

$404K

207
40 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

15%
prescriptions for brand name drugs

Avg: 24%

$83
Average prescription price

Avg: $130

KATHLEEN DEGEN M.D.

Psychiatry

4,373

$625K

271
20 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$143
Average prescription price

Avg: $130

ALAN SIEGAL MD

Psychiatry

4,363

$570K

498
425 are 65+

3%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 24%

$131
Average prescription price

Avg: $130

ASHA QUSBA MD

Psychiatry

4,299

$455K

187
22 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$106
Average prescription price

Avg: $130

STUART FORMAN M.D.

Psychiatry

4,193

$607K

149
14 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 24%

$145
Average prescription price

Avg: $130

BART SLOAN MD

Psychiatry

4,152

$505K

275
149 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$122
Average prescription price

Avg: $130

SHAH NAWAZ M.D.

Psychiatry

4,034

$448K

265
68 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 24%

$111
Average prescription price

Avg: $130

LUIS AVALOS M.D.

Psychiatry

4,027

$369K

221
41 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$92
Average prescription price

Avg: $130

HENRI CZARNY MD

Psychiatry

4,020

$682K

170
23 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 24%

$170
Average prescription price

Avg: $130

ENENGE A'BODJEDI MD

Psychiatry

3,816

$511K

181
47 are 65+

7%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 24%

$134
Average prescription price

Avg: $130

CONSTANTINE ZARIPHES M.D.

Psychiatry

3,740

$290K

270
172 are 65+

6%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 24%

$78
Average prescription price

Avg: $130

DAN OREN M.D.

Psychiatry

3,738

$536K

219
22 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

10%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$143
Average prescription price

Avg: $130

LEELA PANOOR MD

Psychiatry

3,654

$473K

177
25 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

8%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 24%

$129
Average prescription price

Avg: $130

AMANDA SPEICHER M.D.

Psychiatry

3,537

$528K

249
16 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

13%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$149
Average prescription price

Avg: $130

BARCLAY CARAS MD

Psychiatry

3,519

$593K

168
20 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

9%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 24%

$169
Average prescription price

Avg: $130

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank